2seventy bio, Inc.
TSVT
$3.10
$0.4516.98%
Weiss Ratings | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.84 | |||
Price History | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 61.46% | |||
30-Day Total Return | 21.57% | |||
60-Day Total Return | -14.36% | |||
90-Day Total Return | -51.94% | |||
Year to Date Total Return | -66.63% | |||
1-Year Total Return | -78.55% | |||
2-Year Total Return | -90.72% | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -82.62% | |||
52-Week Low % Change | 72.64% | |||
Price | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $15.25 | |||
52-Week Low Price | $1.54 | |||
52-Week Low Price (Date) | Nov 22, 2023 | |||
52-Week High Price (Date) | Feb 06, 2023 | |||
Valuation | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $134.16M | |||
Enterprise Value | 110.03M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -3.91 | |||
Earnings Per Share Growth | -59.03% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.93 | |||
Price/Book (Q) | 0.44 | |||
Enterprise Value/Revenue (TTM) | 0.75 | |||
Price | $3.10 | |||
Enterprise Value/EBITDA (TTM) | -0.63 | |||
Enterprise Value/EBIT | -0.60 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 51.179M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 339 499 9300 | |||
Address | 60 Binney Street Cambridge, MA 02142 | |||
Website | www.2seventybio.com | |||
Country | United States | |||
Year Founded | 2021 | |||
Profitability | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -126.11% | |||
Profit Margin | -126.05% | |||
Management Effectiveness | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -17.04% | |||
Return on Equity | -- | |||
Income Statement | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $145.88M | |||
Total Revenue (TTM) | $145.88M | |||
Revenue Per Share | $2.85 | |||
Gross Profit (TTM) | -$112.07M | |||
EBITDA (TTM) | -$174.40M | |||
EBIT (TTM) | -$183.98M | |||
Net Income (TTM) | -$183.89M | |||
Net Income Avl. to Common (TTM) | -$183.89M | |||
Total Revenue Growth (Q YOY) | -10.25% | |||
Earnings Growth (Q YOY) | -5.54% | |||
EPS Diluted (TTM) | -$3.91 | |||
EPS Diluted Growth (Q YOY) | 20.46% | |||
Balance Sheet | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $250.62M | |||
Cash Per Share (Q) | $4.90 | |||
Total Current Assets (Q) | $277.25M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $306.42M | |||
Current Ratio (Q) | 4.077 | |||
Book Value Per Share (Q) | $6.05 | |||
Total Assets (Q) | $640.81M | |||
Total Current Liabilities (Q) | $68.01M | |||
Total Debt (Q) | $260.16M | |||
Total Liabilities (Q) | $334.38M | |||
Total Common Equity (Q) | $306.42M | |||
Cash Flow | TSVT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$4.56M | |||
Cash from Financing (TTM) | $127.37M | |||
Net Change in Cash (TTM) | -$35.94M | |||
Levered Free Cash Flow (TTM) | -$98.44M | |||
Cash from Operations (TTM) | -$158.74M | |||